Antioxidants in Huntington's disease
- 31 May 2012
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1822 (5), 664-674
- https://doi.org/10.1016/j.bbadis.2011.11.014
Abstract
No abstract availableKeywords
Funding Information
- NIH
- Huntington Disease Society of America
This publication has 139 references indexed in Scilit:
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates NeurodegenerationCell, 2011
- Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington’s disease miceActa Neuropathologica, 2010
- Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuliEMBO Molecular Medicine, 2010
- Hunting-ton for New Proteases: MMPs as the New Target?Neuron, 2010
- Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's DiseaseNeuron, 2010
- Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's diseaseFree Radical Biology & Medicine, 2010
- Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potentialBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Mitochondrial structural and functional dynamics in Huntington's diseaseBrain Research Reviews, 2009
- Huntingtin as an essential integrator of intracellular vesicular traffickingTrends in Cell Biology, 2009
- Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's diseaseDNA Repair, 2009